In conclusion, this is the first study in human cancer patients to systematically analyze and compare the associations of MLKL and necroptosis activation with tumor-infiltrating immune cells in the tissue CCA microenvironment and their impact on clinical outcomes of the patients themselves. This evidence concerns the gene MLKL and cholangiocarcinoma.